Cardinal Health Aktie
| 121,83USD | -1,57USD | -1,27% |
WKN: 880206 / ISIN: US14149Y1082
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99,72 |
| The Vanguard Group, Inc. | 12,92 |
| Vanguard Group, Inc. (Subfiler) | 12,25 |
| SSgA Funds Management, Inc. | 6,01 |
| State Street Corp. | 5,86 |
| BlackRock Fund Advisors | 3,22 |
| Vanguard Total Stock Market ETF | 3,18 |
| BlackRock Advisors LLC | 2,71 |
| Vanguard 500 Index Fund | 2,67 |
| BlackRock Institutional Trust Co. NA | 2,67 |
| Geode Capital Management LLC | 2,38 |
| Vanguard Mid Cap Index Fund | 2,14 |
| Pacer Fds. Tr. - US Cash Cows 100 ETF | 1,78 |
| Pacer Advisors, Inc. | 1,77 |
| BlackRock Equity Dividend Fund | 1,74 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 48 000 | 47 300 | 46 500 | 48 000 | 48 900 |
| Umsatz pro Mitarbeiter in Mio. EUR | 3,19 | 3,44 | 3,90 | 4,27 | 4,64 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 25 940 | 31 048 | 32 935 | 33 833 | 34 884 |
| Summe Anlagevermögen | 14 826 | 13 405 | 10 943 | 9 584 | 10 237 |
| Summe Aktiva | 40 766 | 44 453 | 43 878 | 43 417 | 45 121 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 7 220 | 6 715 | 5 805 | 5 176 | 5 609 |
| Summe Fremdkapital | 38 974 | 42 659 | 44 584 | 46 268 | 48 333 |
| Summe Eigenkapital | 1 792 | 1 794 | -706 | -2 851 | -3 212 |
| Summe Passiva | 40 766 | 44 453 | 43 878 | 43 417 | 45 121 |
Adresse
| 7000 Cardinal Place, 43017 Dublin | |
| Telefon | +1 (614) 757-5000 |
| Internet | http://www.cardinalhealth.com |
Management
|
Aaron E. Alt
Chief Financial Officer |
|
Akhil Johri
Independent Director |
|
Christine Ann Mundkur
Independent Director |
|
Craig Cowman
EVP-Strategic Sourcing & Manufacturer Services |
|
David C. Evans
Independent Director |
|
Debbie Weitzman
Chief Executive Officer-Pharmaceutical Segment |
|
Dennis David
Vice President-Strategy & Business Development |
|
Gregory B. Kenny
Independent Non-Executive Chairman |
|
Jason M. Hollar
Chief Executive Officer & Director |
|
Jessica L. Mayer
Chief Compliance & Legal Officer |
|
Lisa Capodici
Vice President-Investor Relations |
|
Mary C. Scherer
Chief Accounting Officer & Senior Vice President |
|
Matt Sims
Vice President-Investor Relations |
|
Michelle D. Greene
Chief Information Officer & Executive VP |
|
Michelle M. Brennan
Independent Director |
|
Nancy Killefer
Independent Director |
|
Ola M. Snow
Chief Human Resources Officer |
|
Patricia A. Hemingway Hall
Independent Director |
|
Patrick Pope
Secretary, Executive VP & General Counsel |
|
Robert W. Azelby
Independent Director |
|
Sheri H. Edison
Independent Director |
|
Stephen M. Mason
Chief Executive Officer-Medical Segment |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
